A new study by investigators from Mass General Brigham suggests that gabapentin, a relatively common anti-seizure/pain medication, is linked to improved survival in patients with glioblastoma (GBM) — the most common and deadly form of brain cancer in adults. The findings, published in Nature…
Patients with glioblastoma who received gabapentin lived longer, study suggests
